CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-08-24 | Schutz James J Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 1,147,000 | ||
| 2012-08-24 | Miller Robert E Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 852,064 | ||
| 2012-08-24 | French Gregory M Director | Grant or award · Stock Option (Right to Buy) | +23,649 | 512,555 | ||
| 2012-08-24 | Conley Richard K Director | Grant or award · Stock Option (Right to Buy) | +33,108 | 530,678 | ||
| 2012-08-24 | Birnbaum Jay E Director | Grant or award · Stock Option (Right to Buy) | +23,649 | 328,649 | ||
| 2012-08-24 | Alton Gregg H Director | Grant or award · Stock Option (Right to Buy) | +30,405 | 290,405 | ||
| 2012-03-07 | Schutz James J Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +187,500 | 997,000 | ||
| 2012-03-07 | Miller Robert E Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +62,500 | 702,064 | ||
| 2012-01-12 | French Gregory M Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 488,906 |
Page 13 of 13 · 249 trades